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AbsTrACT
background The cOViD-19 pandemic has disrupted 
established care paths worldwide. Patient awareness 
of the pandemic and executive limitations imposed on 
public life have changed the perception of when to seek 
care for acute conditions in some cases. We sought 
to study whether there is a delay in presentation for 
acute ischemic stroke patients in the first month of the 
pandemic in the Us.
Methods The interval between last- known- well 
(lKW) time and presentation of 710 consecutive 
patients presenting with acute ischemic strokes to 
12 stroke centers across the Us were extracted from 
a prospectively maintained quality database. We 
analyzed the timing and severity of the presentation in 
the baseline period from February to March 2019 and 
compared results with the timeframe of February and 
March 2020.
results There were 320 patients in the 2- month 
baseline period in 2019, there was a marked decrease in 
patients from February to March of 2020 (227 patients 
in February, and 163 patients in March). There was no 
difference in the severity of the presentation between 
groups and no difference in age between the baseline 
and the cOViD period. The mean interval from lKW to 
the presentation was significantly longer in the cOViD 
period (603±1035 min) compared with the baseline 
period (442±435 min, P<0.02).
Conclusion We present data supporting an association 
between public awareness and limitations imposed on 
public life during the cOViD-19 pandemic in the Us and 
a delay in presentation for acute ischemic stroke patients 
to a stroke center.
InTroduCTIon
The SARS- CoV-2 virus pandemic and its clinical 
syndrome, COVID-19, is causing significant disrup-
tion to established care paths, including for acute 
conditions such as acute ischemic stroke. Since the 
initially slow recognition of the issue, a breakpoint 
was reached with the first reported death attribut-
able to the novel coronavirus in the US on February 
29, 2020. Public awareness has increased dramati-
cally.1 During March 2020, several states in the US 
have declared a state of emergency and have imple-
mented restrictions on business, travel, and social 
life.
There have been anecdotal reports of a reduc-
tion in cases of acute neurological injury, including 
acute ischemic stroke, and also reports in delays 
in presentation for both neurological and cardiac 
disease,2 suggesting that patients are not seeking 
timely and appropriate medical care for these 
conditions.3 On the other hand, some of the most 
seriously ill COVID-19 patients are presenting with 
cardiac symptoms.4 There is growing recognition 
that COVID-19 may not be confined to the respi-
ratory system, and may even have neuro- invasive 
features that can lead to devastating hemorrhagic 
events.5–7 In some population- dense areas in the US, 
concerns about the incidence of strokes in younger 
patients with COVID-19 have been raised.8
Here we aim to quantify the influence of the 
COVID-19 pandemic on the timing of presentation 
of all acute ischemic stroke patients. We hypothe-
size that patients may be delaying care for stroke 
symptoms due to fears related to the pandemic.
MeThods
We gathered an anonymized limited data set from 
comprehensive stroke centers at 12 participating 
institutions across six states, based on the prospec-
tive ongoing data collection that is entered into the 
American Heart Association ‘Get With The Guide-
lines’ (GWTG) database.9 We compared the period 
of February and March 2019 (the baseline period) 
to February 2020 (the ‘pre- COVID’ period) and 
March 2020 (the ‘COVID’ period). The grouping 
arose naturally from an analysis of Google searches 
(figure 1), denoting the relative interest of the 
search terms ‘COVID’ or ‘Coronavirus’ on the 
Google search engine. Consistent with the time-
line of events surrounding COVID-19 in the US, 
there appears to be very little public awareness 
before March 1, 2020. Centers were selected based 
on their ability to respond to a rapid data request 
and range in characteristic from urban (eight) to 
suburban (three) to rural (one) location. No center 
was located in an area of resource exhaustion.
Each center contributed a consecutive list of 
patients who presented with an acute ischemic 
stroke as adjudicated by the GTWG database entry 
of the final diagnosis. The reported variables were 
limited to the calendar week of presentation, the 
interval between the ‘last- known- well’ timepoint 
(LKW) and the time of arrival to the reporting 
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Figure 1 Google trends analysis of the relative interest in the search terms around COVID-19. The graph is scaled relative to the peak interest.
Figure 2 Development of the number of patients presenting with 
acute ischemic stroke per calendar week.
comprehensive stroke center in minutes, and the first documented 
National Institutes of Health Stroke Scale (NIHSS), which was 
considered a proxy for the severity of stroke presentation.
This research as done under the guidance of the Institutional 
Review Board and exempted (Geisinger IRB 2016–0483).
statistical analysis
The study design is a retrospective, unspecified analysis of 
routinely and prospectively entered data of a standard quality 
database used to ensure quality standards for acute stroke 
patients. The structure of this database has been described 
before.8 Data were analyzed using JMP, Version 14.0 (SAS Insti-
tute Inc., Cary, NC). Groups were compared using Student’s 
t- test.
resulTs
Patient characteristics
From February to March 2019, designated the baseline period, 
320 patients presented with a final diagnosis of acute ischemic 
stroke. In February 2020, designated the pre- COVID period, 
227 distinct patients were analyzed. In March 2020, designated 
the COVID period, 163 patients were available for analysis, for 
a total of 710 patients analyzed.
The number of cases recorded by the week number of the 
year showed a general increasing trend in 2019, in line with 
the expectation of developing more optimal patient care path-
ways and systems of care.10 In the COVID period in 2020, we 
observed a drop in the absolute number of cases per calendar 
week (figure 2).
stroke presentation
The median age was 70±14 (SD) years overall, The mean age of 
patients who presented in the baseline period was 67±15 years, 
slightly younger than in the pre- COVID period (70±14 years) 
and the COVID period (69±14 years)(see online supplemen-
tary figure 1). The difference between the baseline and the pre- 
COVID period was statistically significant (P<0.02), but there 
was no significant difference between the baseline and COVID 
or pre- COVID and COVID groups, P=0.07 and P=0.55, 
respectively.
There was no significant difference between the severity of 
presentation, as the mean initial NIHSS was 9.2, 9.7, and 9.6 
for the baseline, pre- COVID, and COVID period, respectively 
(P=0.79)(see online supplementary figure 2).
The mean time interval between LKW and presentation to the 
stroke center was 442±435 min for the baseline, 552±630 min 
for the pre- COVID, and 603±1035 min for the COVID period. 
The difference of 160 min average increase in time between 
LKW to presentation between the baseline period and COVID 
period was significant (P<0.03) (figure 3).
We performed a sensitivity analysis to exclude an effect driven 
by strokes with less disabling presentations and excluded patients 
with NIHSS<=3 from the analysis. The mean LKW- presentation 
interval for patients with NIHSS >4 was 405±50 min for the 
baseline and 613±70 min for the COVID period, remaining 
significant (P<0.02).
dIsCussIon
Stroke and resultant outcomes have considerable socioeco-
nomic impact,11 and much time and effort have been spent over 
the past few years to standardize care recommendations12 and 
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Figure 3 Time interval between last- known- well time (LKW) and 
arrival at the stroke center (minutes).
create systems of care.10 COVID-19 has been putatively linked 
to an increased incidence of cerebrovascular and cardiovascular 
events.8 13–15 A pooled analysis of several studies that have been 
published to date suggested that there is a 2.5- fold increase in 
the incidence of strokes and poor outcomes or mortality.16
Concomitantly there have been anecdotal reports from physi-
cians in the US regarding a decrease in the number of acute 
cardiovascular and cerebrovascular emergencies, contrasted by 
some reports in the higher affected areas reporting an increase 
or concerns about the severity of strokes or the age of presen-
tation,3 8 leading to conflicting perceptions of the overall stroke 
burden during the pandemic.
Our results suggest that there is another variable to consider, 
namely the delay of presentation. Similar results were reported in 
a limited study of cardiac interventions in Hong Kong in January 
2020, in which substantial increases in time from symptom onset 
to medical contact were observed.2 This may be due to patients’ 
perceived concerns or outright fear of interacting with the health-
care system, leading to reluctance in seeking medical help shortly 
after symptom onset. Delays in care have been described in other 
settings, including heart failure and (during COVID-19) tubercu-
losis.17 18 The common thread is that the factors leading to delays 
when seeking care are poorly understood and generally not well 
studied but include factors such as fear, embarrassment, and 
well- being.
In the case of this current pandemic, we show an increase in the 
mean interval between the LKW time and the time of presenta-
tion to the hospital. We have shown no change in stroke severity 
in the cohort described in comparison to the baseline, though the 
full effect of the pandemic is still not known. The result remains 
significant when excluding less severe strokes with NIHSS<=3. 
Seeking care as early as possible remains paramount since a delay in 
stroke treatment has long- lasting consequences.12 Public measures 
imposing social distancing, stay- at- home, or shelter- in- place orders 
are necessary measures to limit the spread of COVID-19. However, 
they may have the unintended effect of increasing the perceived 
downsides of seeking care for non- COVID related diseases, leading 
to delayed care and worse outcomes.
Our work does not incorporate emergency medical services 
(EMS) activation rates or the interval between LWK and the acti-
vation of EMS which may be a potentially more granular time 
interval to study the delay between onset of symptoms and seeking 
care. Unfortunately, no systematic data collection was available for 
analysis and depending on the geography a variable number of 
patients are brought to the hospital directly.
Our analysis points to the need for a public education campaign. 
A future additional resurgence of COVID-19 or other pandemic 
outbreaks could occur. Helping the public to understand the more 
imminent risks may avoid additional burden on the healthcare 
system and improve the recovery potential of the patients.19 20 We 
have limited information about the impact of patient screening 
protocols on the transfer of patients. Widespread testing of asymp-
tomatic patients had not been implemented in the US during the 
study period, and we do not believe that non- testing screening 
protocols can account for the difference seen in our results.
Limitations of this study include the limited dataset gathered, 
which is reflected in the relatively small number of stroke centers 
included, necessitated by the need to respond to a rapid data request 
and the related limited geographic sampling across the US. Simi-
larly, the rapidly changing landscape of the COVID-19 pandemic, 
including more definitive effects of social distancing may not yet 
be captured in this dataset. We do not attempt to analyze the 
difference in referral pattern and patient flows between different 
centers in this study, nor does this analysis take the intermediate 
stop or bypass of a first hospital or stroke center into account. We 
assume that all factors that would contribute to the aggregate effi-
ciency of the stroke referral system of the centers included here 
remains at least stable if not improved between the baseline and the 
COVID period. This is based on the systematic process improve-
ment efforts that all stroke centers are engaged in. These efforts are 
typically directed toward reducing intervals from door to needle 
or revascularization. We correlate the presence of COVID-19 as a 
single changed variable but do not believe that other confounders 
would be able to explain the significant effect size demonstrated 
in our results.
ConClusIon
In this work, we present new data supporting that the outbreak of 
the COVID-19 pandemic in the US is associated with a delay in 
presentation of patients with acute ischemic stroke. We urge poli-
cymakers and patient advocates to consider these results in future 
decision making and raise awareness of the need for patients to 
seek appropriate and timely medical attention for stroke symp-
toms, even in the face of the current or future pandemic crisis.
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